Provectus Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc.

PVCT 0.0700

+1.4%

Nov 21 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: LT2011 who wrote (11666)	11/16/2012 10:01:03 AM
From: NTTG	5 Recommendations Read Replies (1) of 13111

I dont think you can identify one bad apple here, there is a group think problem at PVCT that ranges from; the over-statement of aspirational goals, through shortcomings in the development plan and failure to anchor the evidence for RB use, to inappropriate fiscal management of spending and compensation. Since MGT has no direct experience bringing a drug through development, and the BOD has historically been devoid of people with critical experience in drug development, PVCT spent a lot of time in the early years chasing elusive rabbits....so much so that their target MM market is now filling with a diverse collection of interesting and successful new treatment options that will drive therapy in new directions....PV10 and PH-10 data is aging as I type. Better to have taken one goal to completion that to continue trying to shoot at new oncology, dermatology, anti-infective, or who knows what other targets MGT has fantasies about. So I guess I would fire them all........as a recent owner (again) of PVCT stock it is looking more and more like the only realistic prospect for a sizable SP uptick in the near future.....IMO

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next